Filed: 8/14/2024ACC: 0001104659-24-089632
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $1.57B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$1.57B
Total AUM (reported)
150.02M
Total Shares
Allocation by class
COM$1.40B89.2%
COM NEW$102.40M6.5%
CLASS A ORD SHS$21.08M1.3%
COM SHS$20.16M1.3%
SPONSORED ADS$17.79M1.1%
CL A ORD SHS$7.54M0.5%
ORD SHS$614.3K0.0%
Portfolio Concentration
Top 3$520.66M33.2%
4–10$493.55M31.4%
11–25$462.87M29.5%
Rest$93.16M5.9%
Top 3 weight
33.2%
Top 10 weight
64.6%
Voting Authority Distribution
Total shares with voting rights: 150.02M
Sole
Full voting authority
150.02M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$334.21M
21.28%
Sole
8.49M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares4.03M
TypeSH
Market value$94.10M
5.99%
Sole
4.03M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares4.40M
TypeSH
Market value$92.36M
5.88%
Sole
4.40M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares12.76M
TypeSH
Market value$87.30M
5.56%
Sole
12.76M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$76.72M
4.89%
Sole
2.17M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.26M
TypeSH
Market value$74.74M
4.76%
Sole
1.26M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.25M
TypeSH
Market value$73.62M
4.69%
Sole
6.25M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.40M
TypeSH
Market value$63.84M
4.07%
Sole
3.40M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.69M
TypeSH
Market value$63.13M
4.02%
Sole
2.69M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares2.09M
TypeSH
Market value$54.20M
3.45%
Sole
2.09M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$50.51M
3.22%
Sole
3.88M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.68M
TypeSH
Market value$47.92M
3.05%
Sole
5.68M
Shared
0.00
None
0.00
APPLIED THERAPEUTICS INC
SOLEShares9.54M
TypeSH
Market value$44.57M
2.84%
Sole
9.54M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares16.22M
TypeSH
Market value$38.27M
2.44%
Sole
16.22M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares3.61M
TypeSH
Market value$32.84M
2.09%
Sole
3.61M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares1.82M
TypeSH
Market value$32.75M
2.09%
Sole
1.82M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares4.39M
TypeSH
Market value$31.07M
1.98%
Sole
4.39M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares706.13K
TypeSH
Market value$29.21M
1.86%
Sole
706.13K
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares2.83M
TypeSH
Market value$26.65M
1.70%
Sole
2.83M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$24.07M
1.53%
Sole
1.38M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares3.41M
TypeSH
Market value$23.22M
1.48%
Sole
3.41M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares11.33M
TypeSH
Market value$22.77M
1.45%
Sole
11.33M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares6.02M
TypeSH
Market value$21.08M
1.34%
Sole
6.02M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares9M
TypeSH
Market value$20.16M
1.28%
Sole
9M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares1.35M
TypeSH
Market value$17.79M
1.13%
Sole
1.35M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $334.21M 21.28% | 8.49M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 4.03M | SH | $94.10M 5.99% | 4.03M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 4.40M | SH | $92.36M 5.88% | 4.40M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 12.76M | SH | $87.30M 5.56% | 12.76M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $76.72M 4.89% | 2.17M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 1.26M | SH | $74.74M 4.76% | 1.26M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.25M | SH | $73.62M 4.69% | 6.25M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.40M | SH | $63.84M 4.07% | 3.40M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.69M | SH | $63.13M 4.02% | 2.69M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 2.09M | SH | $54.20M 3.45% | 2.09M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $50.51M 3.22% | 3.88M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 5.68M | SH | $47.92M 3.05% | 5.68M | 0.00 | 0.00 |
APPLIED THERAPEUTICS INCSOLE | COM | 9.54M | SH | $44.57M 2.84% | 9.54M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 16.22M | SH | $38.27M 2.44% | 16.22M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 3.61M | SH | $32.84M 2.09% | 3.61M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 1.82M | SH | $32.75M 2.09% | 1.82M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 4.39M | SH | $31.07M 1.98% | 4.39M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 706.13K | SH | $29.21M 1.86% | 706.13K | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 2.83M | SH | $26.65M 1.70% | 2.83M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $24.07M 1.53% | 1.38M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 3.41M | SH | $23.22M 1.48% | 3.41M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 11.33M | SH | $22.77M 1.45% | 11.33M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 6.02M | SH | $21.08M 1.34% | 6.02M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 9M | SH | $20.16M 1.28% | 9M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.35M | SH | $17.79M 1.13% | 1.35M | 0.00 | 0.00 |
Page 1 of 2